BRAF and non-small cell lung carcinoma: ,60,61 The study by Awad and colleagues7 included 236 patients with NSCLC carrying BRAF mutations, of which class I mutations accounted for approximately 45% (107 cases), class II mutations for 32% (75 cases), and class III mutations for 23% (54 cases).